Internal Medicine, Hematology & Oncology · Spartanburg, SC
NPI
1942594155
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
101 E Wood St
Spartanburg, SC, 29303
Phone (864) 560-7050
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
1,751 services
Medicare patients, 2024
573
Average age 76
Drug cost, 2024
$4.2M
3,300 prescriptions
Company payments, 2025
$2,325
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Humeniuk was code 99215 (office e&m - established), 431 times for 184 patients. In total Michael S Humeniuk billed 1,751 services in 19 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 431 | 184 | $106.25 | $46K |
| 99214 Office E&M - Established | Facility | 418 | 222 | $69.10 | $29K |
| 99215 Office E&M - Established | Office | 289 | 131 | $105.34 | $30K |
| 99214 Office E&M - Established | Office | 199 | 115 | $68.42 | $14K |
| 99213 Office E&M - Established | Facility | 125 | 93 | $42.14 | $5,267 |
| 99213 Office E&M - Established | Office | 70 | 50 | $42.17 | $2,952 |
| 99231 Hospital E&M - Subsequent | Facility | 64 | 38 | $38.12 | $2,440 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 33 | $60.38 | $3,019 |
| 99233 Hospital E&M - Subsequent | Facility | 36 | 30 | $90.28 | $3,250 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $100.58 | $1,810 |
| 99205 Office E&M - New | Office | 13 | 13 | $142.03 | $1,846 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $135.19 | $1,622 |
By year: 2022 $128K for 1,890 services; 2023 $157K for 2,313 services; 2024 $142K for 1,751 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Humeniuk prescribed most often to Medicare patients was Abiraterone Acetate, with 682 prescriptions and refills. In total Michael S Humeniuk wrote 3,300 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 682 | 705 | 88 | $1.9M |
| Prednisone Generic | 661 | 844 | 149 | $2,325 |
| Quetiapine Fumarate Generic | 136 | 204 | 39 | $679 |
| Gabapentin Generic | 99 | 119 | 24 | $794 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 98 | 98 | 34 | $4,394 |
| Levothyroxine Sodium Generic | 84 | 178 | 24 | $942 |
| Xtandi Enzalutamide | 79 | 79 | Under 11 | $1.1M |
| Eliquis Apixaban | 77 | 105 | 18 | $61K |
| Ondansetron Hcl Generic | 69 | 71 | 33 | $1,387 |
| Morphine Sulfate Generic | 64 | 64 | 35 | $2,417 |
| Tamsulosin Hcl Generic | 60 | 120 | 20 | $738 |
| Prochlorperazine Maleate Generic | 60 | 60 | 31 | $1,824 |
| Potassium Chloride Generic | 52 | 76 | 13 | $738 |
| Morphine Sulfate Er Morphine Sulfate | 51 | 51 | 21 | $896 |
| Dexamethasone Generic | 45 | 45 | 23 | $595 |
Brand drugs: 365 claims; generic drugs: 2,935 claims; opioid claims: 329.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Humeniuk $2,325 ($2,325 in general payments such as food, travel and fees) from 32 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $199.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $199 |
| Daiichi Sankyo Inc. 4568.T | 8 | $195 |
| Janssen Biotech, Inc. JNJ | 11 | $181 |
| Pfizer Inc. PFE | 9 | $180 |
| Dendreon Pharmaceuticals LLC | 2 | $163 |
| Gilead Sciences, Inc. GILD | 5 | $152 |
| Immunocore Limited IMCR | 2 | $144 |
| Intuitive Surgical, Inc. ISRG | 1 | $108 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $106 |
| Abbvie Inc. ABBV | 6 | $97.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.